Israeli team develops 'anti-diabetes drug'

463 million people have been diagnosed with diabetes worldwide

and up to 95% of this number have Type 2.

Israeli team develops 'anti-diabetes drug'

Read More - Click Here

Hi, thanks for stopping by!

Concenter BioPharma is a subsidiary of Silkim Pharma Ltd., which developed a novel, protected PLATFORM of drugs for proven treatments of multiple indications. 


Our PLATFORM is the result of extensive investigation of animal models of human diseases.

Let the news
come to you.

  • LinkedIn
  • Facebook
  • Twitter


Thank you for your interest in Concenter BioPharma.

To contact us please reach us via: